Theraloc
Term · Oncology and biomedicine · MLC-T-ONC-008637
A substance being studied in the treatment of some types of cancer. Theraloc binds to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein may help keep cancer cells from growing. Theraloc is a type of monoclonal antibody. Also called nimotuzumab.
| Identifier | MLC-T-ONC-008637 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | nimotuzumab |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008637",
"term": "Theraloc",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. Theraloc binds to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein may help keep cancer cells from growing. Theraloc is a type of monoclonal antibody. Also called nimotuzumab.",
"synonyms": [
"nimotuzumab"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/theraloc/"
}
Record 16,231 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.